Cervical Cancer Screening Device for the Developing World
Though highly treatable, cervical cancer is the third most common cancer worldwide and is often fatal, with 80% of cases occurring in the developing world. This is due in part to a lack of effective screening programs.
Access to life-saving screenings is impeded for many women in developing countries by their remote location, lack of qualified screeners, and social stigma.
A team of researchers from the University of Pennsylvania worked with Smithwise to develop a low-cost cervical cancer screening device that can be used by a patient to capture images of her cervix for professional evaluation offsite.
Subscribe to MedTech Mindset!
Receive the latest industry insights, news, podcasts, videos, and events for the medtech audience from your friends at Smithwise + Catapult (average 2 emails monthly).
MedTech Leaders Trust Smithwise + Catapult
Smithwise partners with innovators to transform novel concepts into market-ready medical devices that improve and save lives.
From surgical instrumentation and point-of-care diagnostics to medical robotics, wearables, and drug delivery devices, Smithwise accelerates the development of breakthrough medical technologies from napkin sketch through production.